Blastic plasmacytoid dendritic cell neoplasm: Extensive disease, Langer lines, and blood burden in a retrospective study of 66 cases - 19/02/25
Doi : 10.1016/j.jaad.2024.11.010
Christopher J. Fay, MD a, Jesse P. Hirner, MD b, Shai Shimony, MD c, d, e, Ai-Tram Bui, MD f, Andrew A. Lane, MD, PhD c, d, Nicole R. LeBoeuf, MD, MPH a, d, ⁎ 
a Department of Dermatology, Brigham and Women's Hospital, and the Center for Cutaneous Oncology, Dana-Farber/Brigham Cancer Center, Boston, Massachusetts
b Department of Dermatology, University of Missouri Health Care, Columbia, Missouri
c Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts
d Harvard Medical School, Boston, Massachusetts
e Rabin Medical Center and Faculty of Medicine, Tel Aviv University, Israel
f Department of Dermatology, Stanford University Medical Center, Stanford, California
∗Correspondence to: Nicole R. LeBoeuf, MD, MPH, Center for Cutaneous Oncology, Dana-Farber/Brigham Cancer Center, 450 Brookline Avenue, Boston, MA 02115Center for Cutaneous OncologyDana-Farber/Brigham Cancer Center450 Brookline AvenueBostonMA02115
Key words : blastic natural-killer cell lymphoma, blastic plasmacytoid dendritic cell neoplasm, CD4+CD56+ hematodermic neoplasm, Langer lines
| Funding sources: None. |
|
| IRB approval status: Reviewed and approved, IRB Protocol Number 12-328. |
© 2024
Publié par Elsevier Masson SAS.
Vol 92 - N° 3
P. 628-630 - mars 2025 Retour au numéro
Article précédent
- Clinical presentations and treatment outcomes in extragenital lichen sclerosus: A 34-year multiinstitutional retrospective review
- Shawn Afvari, Subin Lim, Britney Nguyen, Ruhi Kanwar, Christina Kraus, Neda Shahriari, Avery H. LaChance
- Cutaneous adverse events of osimertinib in diverse patient populations with epidermal growth factor receptor-mutated non-small cell lung cancer: A retrospective cohort analysis
- Daniel S. Alicea, Emily Miao, Peter Ch'en, Steven W. Tuckman, Nitin Ohri, Balazs Halmos, Haiying Cheng, Matthew Lee, Beth N. McLellan
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?